Search

everythinglearnresearchcommunity

for

Search:↓

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Hair loss linked to higher heart disease risk in both men and women.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Non-obese women with hair loss have higher heart disease risk.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.